Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Renal allograft biopsies at Groote Schuur Hospital: a histopathologic descriptive study with molecular insights

Background: Kidney transplantation is the definitive treatment for end-stage kidney disease. Immune-mediated rejection remains a barrier to success. It is diagnosed through the Banff classification, which incorporates histopathology and biomarkers (C4d/donor specific antibodies (DSA)). In resource-l...

Full description

Saved in:
Bibliographic Details
Main Author: Lunn, Jarryd
Other Authors: Price, Brendon
Format: Thesis
Language:English
English
Published: Department of Pathology 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613671661764608
access_status_str Open Access
author Lunn, Jarryd
author2 Price, Brendon
author_browse Lunn, Jarryd
Price, Brendon
author_facet Price, Brendon
Lunn, Jarryd
author_sort Lunn, Jarryd
collection Thesis
description Background: Kidney transplantation is the definitive treatment for end-stage kidney disease. Immune-mediated rejection remains a barrier to success. It is diagnosed through the Banff classification, which incorporates histopathology and biomarkers (C4d/donor specific antibodies (DSA)). In resource-limited settings, DSA testing can be challenging, necessitating reliable alternatives. Aim: This study evaluated: (1) rejection patterns at our hospital; (2) the impact of the Banff 2022 criteria with a computer-assisted tool; and (3) the utility of C4d as a predictor of DSA status. Methods: We analysed 197 for-cause historic biopsy reports between 2015-2022 for details of rejection- and non-rejection pathologies, Banff lesion scores and DSA status. A computer- based tool was used on historic data to re-calculate Banff 2022 classification diagnoses, which were compared to historic diagnoses. Logistic regression assessed C4d as a predictor of DSA. Results: The cohort showed a male predominance (59.3%). Sixty-three percent of cases showed non-rejection pathology, with acute tubular injury and pyelonephritis being the most frequent. TCMR was the most common form of rejection (17.3%), with AMR being the least common (7.6%). The computer-based tool demonstrated agreement of 92.4% for AMR/TCMR and 84.6% of borderline TCMR, but was confounded by non-rejection pathologies. C4d predicted DSA-positivity with 95% specificity but only 29.5% sensitivity. Conclusion: The Banff 2022 criteria were additive in rejection diagnosis, with a computer-based tool acting as a guide but not a pure diagnostic tool. The high specificity of C4d makes it valuable where DSA testing is limited. Contribution: This study validates the role of the Banff 2022 in our setting, aided by a computer-based tool that aims to decrease logical- and transcription errors when using the complex Banff classification. It also demonstrates C4d's role as a practical DSA proxy, offering actionable solutions in resource-limited settings.
format Thesis
id oai:open.uct.ac.za:11427/42407
institution University of Cape Town (South Africa)
language English
eng
last_indexed 2026-06-10T12:39:51.633Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2025
publishDateRange 2025
publishDateSort 2025
publisher Department of Pathology
publisherStr Department of Pathology
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/42407 Renal allograft biopsies at Groote Schuur Hospital: a histopathologic descriptive study with molecular insights Lunn, Jarryd Price, Brendon Chetty, Dharshnee Ikumi, Nadia Renal transplantation Banff 2022 classification renal rejection prevalence rejection biomarkers digital pathology algorithm C4d-DSA prediction Antibody mediated rejection T-cell mediated rejection Background: Kidney transplantation is the definitive treatment for end-stage kidney disease. Immune-mediated rejection remains a barrier to success. It is diagnosed through the Banff classification, which incorporates histopathology and biomarkers (C4d/donor specific antibodies (DSA)). In resource-limited settings, DSA testing can be challenging, necessitating reliable alternatives. Aim: This study evaluated: (1) rejection patterns at our hospital; (2) the impact of the Banff 2022 criteria with a computer-assisted tool; and (3) the utility of C4d as a predictor of DSA status. Methods: We analysed 197 for-cause historic biopsy reports between 2015-2022 for details of rejection- and non-rejection pathologies, Banff lesion scores and DSA status. A computer- based tool was used on historic data to re-calculate Banff 2022 classification diagnoses, which were compared to historic diagnoses. Logistic regression assessed C4d as a predictor of DSA. Results: The cohort showed a male predominance (59.3%). Sixty-three percent of cases showed non-rejection pathology, with acute tubular injury and pyelonephritis being the most frequent. TCMR was the most common form of rejection (17.3%), with AMR being the least common (7.6%). The computer-based tool demonstrated agreement of 92.4% for AMR/TCMR and 84.6% of borderline TCMR, but was confounded by non-rejection pathologies. C4d predicted DSA-positivity with 95% specificity but only 29.5% sensitivity. Conclusion: The Banff 2022 criteria were additive in rejection diagnosis, with a computer-based tool acting as a guide but not a pure diagnostic tool. The high specificity of C4d makes it valuable where DSA testing is limited. Contribution: This study validates the role of the Banff 2022 in our setting, aided by a computer-based tool that aims to decrease logical- and transcription errors when using the complex Banff classification. It also demonstrates C4d's role as a practical DSA proxy, offering actionable solutions in resource-limited settings. 2025-12-05T07:14:56Z 2025-12-05T07:14:56Z 2025 2025-12-05T07:12:16Z Thesis / Dissertation Masters MMed http://hdl.handle.net/11427/42407 en eng application/pdf Department of Pathology Faculty of Health Sciences University of Cape Town
spellingShingle Renal transplantation
Banff 2022 classification
renal rejection prevalence
rejection biomarkers
digital pathology algorithm
C4d-DSA prediction
Antibody mediated rejection
T-cell mediated rejection
Lunn, Jarryd
Renal allograft biopsies at Groote Schuur Hospital: a histopathologic descriptive study with molecular insights
thesis_degree_str Master's
title Renal allograft biopsies at Groote Schuur Hospital: a histopathologic descriptive study with molecular insights
title_full Renal allograft biopsies at Groote Schuur Hospital: a histopathologic descriptive study with molecular insights
title_fullStr Renal allograft biopsies at Groote Schuur Hospital: a histopathologic descriptive study with molecular insights
title_full_unstemmed Renal allograft biopsies at Groote Schuur Hospital: a histopathologic descriptive study with molecular insights
title_short Renal allograft biopsies at Groote Schuur Hospital: a histopathologic descriptive study with molecular insights
title_sort renal allograft biopsies at groote schuur hospital a histopathologic descriptive study with molecular insights
topic Renal transplantation
Banff 2022 classification
renal rejection prevalence
rejection biomarkers
digital pathology algorithm
C4d-DSA prediction
Antibody mediated rejection
T-cell mediated rejection
url http://hdl.handle.net/11427/42407
work_keys_str_mv AT lunnjarryd renalallograftbiopsiesatgrooteschuurhospitalahistopathologicdescriptivestudywithmolecularinsights